Can I use calcium‑channel‑blocker (CCB) ointments for the treatment of anal fissures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, calcium channel blocker (CCB) ointments are effective for treating anal fissures and should be used as first-line medical therapy after conservative measures fail.

Topical CCB ointments are as effective as nitroglycerin for healing anal fissures but cause significantly fewer side effects, making them the preferred topical medical therapy. 1

Treatment Algorithm

First-Line: Conservative Care

Start all patients (especially acute fissures) with:

  • Fiber supplementation
  • Adequate fluid intake
  • Sitz baths
  • Topical analgesics

Approximately 50% of fissures heal with conservative care alone. 1

Second-Line: Topical CCB Therapy

If conservative care fails or symptoms are severe, topical CCB ointments are an acceptable and effective option 1:

  • Healing rates: 52-95% depending on formulation and study 2, 3, 4
  • Mechanism: Reversibly decreases resting anal pressure, promoting healing without permanent sphincter damage 1
  • Side effects: Significantly fewer than nitroglycerin (particularly fewer headaches) 1, 5

Specific CCB Formulations with Evidence:

Nifedipine 0.3% + Lidocaine 1.5% ointment:

  • 94.5% healing rate at 6 weeks 2
  • Reduces mean anal resting pressure by 11% 2
  • Recurrence in only 5.8% of healed patients 2
  • No systemic side effects reported 2
  • This combination is particularly effective 5, 2

Diltiazem 2% ointment:

  • 75% healing rate initially, with additional patients healing after extended treatment 3
  • Minimal side effects (perianal dermatitis in 6%, headaches in 1.4%) 3
  • Recurrences respond well to repeat treatment 3

Comparison to Other Medical Therapies

CCBs vs. Nitroglycerin (GTN):

  • Similar efficacy (CCBs may be slightly better) 1, 4
  • Significantly fewer side effects with CCBs 1, 6
  • Better patient compliance due to tolerability 7

Topical vs. Oral CCBs:

  • Topical formulations are superior: 21.3% failure rate vs. 38.4% with oral 6
  • Topical CCBs have significantly fewer side effects (4.3% vs. 38%) 6
  • No difference in recurrence rates 6

Third-Line: Surgical Options

Reserve lateral internal sphincterotomy (LIS) for:

  • Failed medical therapy
  • Intolerable pain requiring immediate intervention
  • Patient preference after informed discussion

LIS has 95% healing rates but carries risk of permanent minor incontinence 4.

Important Caveats

Commercial availability issue: The AGA guideline notes that appropriately diluted topical CCB preparations were not commercially available in the United States as of 2003 1. However, compounding pharmacies can prepare these formulations, and some formulations may now be available depending on your region 5.

Long-term outcomes: While initial healing rates are excellent, long-term failure rates with topical therapy require monitoring 1. Recurrences typically respond to repeat courses of treatment 2, 3.

Off-midline fissures: Always evaluate for underlying conditions (Crohn's disease, HIV/AIDS, tuberculosis, malignancy) when fissures occur off the posterior midline 1.

Clinical Reasoning

The evidence strongly supports topical CCBs as an intermediate option that combines the safety of conservative therapy with effectiveness approaching surgical intervention. They achieve prompt but temporary sphincter relaxation without the permanent continence risks of surgery 1. Recent trends favor CCBs over nitroglycerin as first-line pharmacologic therapy 7, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.